United States v. Abbott Laboratories

2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 UNITED STATES OF AMERICA, et al. ex rel. Case No.: 20cv286-W (MSB) Everest Principals, LLC, 12

ORDER GRANTING DEFENDANTS’

Plaintiffs, 13 MOTION TO COMPEL DISCOVERY v. 14 [ECF NO. 154] ABBOTT LABORATORIES, et al., 15 Defendants. 16 17 18 This is a qui tam case, wherein Plaintiff-Relator, Everest Principals, LLC (“Relator”) 19 maintains causes of action against Defendants Abbott Laboratories, Abbott Laboratories 20 Inc., Abbott Cardiovascular Systems Inc., and Abbott Vascular Inc. (collectively referred 21 to as “Defendants” or “Abbott”) on behalf of the United States of America (“United 22 States”) and several states for violations of the federal False Claims Act (“FCA”) and 23 analogous state laws. (See ECF No. 85 at 6.) 24 Now pending before this Court is the parties’ briefing regarding Relator’s 25 response to Defendants’ Interrogatory No. 3. (See ECF Nos. 154 & 155.) In short, the 26 parties disagree about whether Relator should be required to provide a complete list of 27 allegedly…